Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human C1QA Antibodies:
anti-Rat (Rattus) C1QA Antibodies:
anti-Mouse (Murine) C1QA Antibodies:
Go to our pre-filtered search.
Human Polyclonal C1QA Primary Antibody for WB - ABIN1944793
Sellar, Blake, Reid: Characterization and organization of the genes encoding the A-, B- and C-chains of human complement subcomponent C1q. The complete derived amino acid sequence of human C1q. in The Biochemical journal 1991
Show all 3 references for ABIN1944793
Human Polyclonal C1QA Primary Antibody for WB - ABIN611353
Steegmaier, Yang, Yoo, Huang, Shen, Yu, Luo, Scheller: Three novel proteins of the syntaxin/SNAP-25 family. in The Journal of biological chemistry 1999
Show all 2 references for ABIN611353
Human Polyclonal C1QA Primary Antibody for FACS, IHC (p) - ABIN391492
Sjöberg, Nyström, Hammarström, Blom: Native, amyloid fibrils and beta-oligomers of the C-terminal domain of human prion protein display differential activation of complement and bind C1q, factor H and C4b-binding protein directly. in Molecular immunology 2008
C1qA globular domain (C1qAgD) was expressed, purified and crystallized.
This study reveled that C1QA having a central role in the bipolar disease and schizophrenia manifestation.
no significant association found to either rs15940 (C1QA) or rs172378 (C1QC (show C1QC Antibodies)) when analysed in just Parkinson disease cases , just controls or combined
Our findings showed that Brugia malayi Calreticulin (show CALR Antibodies) (BmCRT) is responsible for the prevention of classical complement pathway activation via its interaction with the first component C1q of the human host
interaction with calreticulin (show CALR Antibodies) controls the phagocyte inflammatory status
A newly characterized leech calreticulin (show CALR Antibodies) (HmCalR) has been shown to interact with C1q and participate to the HmC1q-dependent microglia accumulation.
Both CERT (show COL4A3BP Antibodies) isoforms, when immobilized, were found to bind the globular head region of C1q and to initiate the classical complement pathway. C1q binds endogenous CERTL (show COL4A3BP Antibodies) on the surface of apoptotic cells.
Most likely, C1q bridges calreticulin (show CALR Antibodies) on the parasite surface with its receptor orthologue on human placental cells, thus facilitating the first encounter between the parasite and the fetal derived placental tissue.
Data indicate that Cna (show CAN Antibodies) binds to C1q.
Analysis of its interaction properties by surface plasmon resonance shows that rC1q retains the ability of serum C1q to associate with the C1s (show C1S Antibodies)-C1r-C1r (show C1R Antibodies)-C1s (show C1S Antibodies) tetramer, to recognize physiological C1q ligands such as IgG and pentraxin 3 (show PTX3 Antibodies)
Single nucleotide polymorphisms in and around the C1q genes, C1qA, C1qB (show C1QB Antibodies) and C1qC (show C1QC Antibodies), correlated with C1q serum levels and may be a risk for the development of rheumatoid arthritis.
C1q is involved in the pristane-mediated enhanced inflammatory response to TLR7 (show TLR7 Antibodies) stimulation.
Data (including data from studies in mutant mice) suggest exercise prevents age-related neurovascular decline, up-regulation of C1qa, and down-regulation of astrocytic Apoe (show APOE Antibodies); this preventive effect of exercise does not occur in Apoe (show APOE Antibodies)-deficient mice.
critical role in activation of beta-catenin (show CTNNB1 Antibodies) signalling in hypertensive arterial remodelling
Data (including data on knockout mice) suggest, in absence of Trem2 (triggering receptor expressed on myeloid cells 2 (show TREM2 Antibodies)), pulmonary macrophages selectively produce elevated levels of C1q resulting in enhanced phagocytosis during pneumococcal pneumonia.
C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 (show SOD1 Antibodies) mice.
C1q-induced LRP1B (show LRP1B Antibodies) and GPR6 (show GPR6 Antibodies) proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-beta neurotoxicity
Findings suggest the unexpected role of complement C1q in Wnt (show WNT2 Antibodies) signal transduction and modulation of mammalian aging.
Leukocyte recruitment and C1q-hemolytic activity was restored to wild type levels when CD93 (show CD93 Antibodies) was expressed on either hematopoietic cells or nonhematopoietic cells in bone marrow chimeric mice
C1q, a marker of microglial activation, is upregulated in the nigrostriatal system following subchronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP (show PTPN2 Antibodies)); nigrostriatal dopaminergic injury is not affected by C1q in this model of Parkinson disease.
This gene encodes a major constituent of the human complement subcomponent C1q. C1q associates with C1r and C1s in order to yield the first component of the serum complement system. Deficiency of C1q has been associated with lupus erythematosus and glomerulonephritis. C1q is composed of 18 polypeptide chains: six A-chains, six B-chains, and six C-chains. Each chain contains a collagen-like region located near the N terminus and a C-terminal globular region. The A-, B-, and C-chains are arranged in the order A-C-B on chromosome 1. This gene encodes the A-chain polypeptide of human complement subcomponent C1q.
complement component 1, q subcomponent, alpha polypeptide
, complement C1q subcomponent subunit A
, complement component 1, q subcomponent, A chain
, complement component C1q, A chain
, complement C1qA